Michael Andrew Chambers, Director: Sarepta Therapeutics SRPT Buy · Filed 24/08/20

Trade details

Type: Insider buy
Amount: $2,451,153.04
Shares · price: 18,284 sh · $134.06 a share
Held after: 278,386 sh
Stock: Sarepta Therapeutics SRPT
Person: Michael Andrew ChambersDirector
Trade date: 24/08/16
Filed: 24/08/20
Days to filing: 4 days

First buy in 1 years

Since the last buy: 1 years
Last buy: 23/08/14
Insiders buying this week: 1 insiders
Holding change: +7.0%

Sarepta Therapeutics trades, last 26 weeks

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/17~24/09/15

Michael Andrew Chambers's recent trades

Michael Andrew ChambersDirector
BuySarepta Therapeutics
Buy
Sarepta Therapeutics
SRPT
$1.7M
13,106 sh
$1.7M
Filed 24/08/20
Traded 24/08/16
Michael Andrew ChambersDirector
BuySarepta Therapeutics
Buy
Sarepta Therapeutics
SRPT
$760.6K
5,648 sh
$760.6K
Filed 24/08/20
Traded 24/08/16
Michael Andrew ChambersDirector
BuySarepta Therapeutics
Buy
Sarepta Therapeutics
SRPT
$649.4K
5,947 sh
$649.4K
Filed 23/08/15
Traded 23/08/14
Michael Andrew ChambersDirector
BuySarepta Therapeutics
Buy
Sarepta Therapeutics
SRPT
$443.1K
4,032 sh
$443.1K
Filed 23/08/15
Traded 23/08/14
Michael Andrew ChambersDirector
BuySarepta Therapeutics
Buy
Sarepta Therapeutics
SRPT
$2.6M
23,686 sh
$2.6M
Filed 23/08/14
Traded 23/08/11

Michael Andrew Chambers, Director — bought $2.5M of Sarepta Therapeutics SRPT · 18,284 sh @ $134.06 | Whalegun